{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:23:21Z","timestamp":1780640601162,"version":"3.54.1"},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JADPRO"],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:p>In recent years, chimeric antigen receptor (CAR) T-cell therapy has emerged as an effective and potentially paradigm-shifting therapy for patients with refractory lymphoma and myeloma. This novel therapy involves engineering T cells to recognize specific antigens on the surface of cancer cells. Several CAR T-cell products are approved by the US Food and Drug Administration as a result of numerous clinical trials. Due to the complexity of these studies and the high level of care required for CAR T-cell therapy patients, the role of the research advanced practice provider (APP) has become increasingly central to the success of CAR T-cell trials. This review article explores the vital role of the research APP in CAR T-cell clinical trials.<\/jats:p>","DOI":"10.6004\/jadpro.2023.14.1.5","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T14:45:52Z","timestamp":1674657952000},"page":"54-66","source":"Crossref","is-referenced-by-count":3,"title":["The Role of the Research Advanced Practice Provider in CAR T-Cell Clinical Trials"],"prefix":"10.6004","volume":"14","author":[{"given":"Ly","family":"Dsouza, PA-C, MPAS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","published-online":{"date-parts":[[2023,1,1]]},"container-title":["Journal of the Advanced Practitioner in Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T14:46:00Z","timestamp":1674657960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.advancedpractitioner.com\/issues\/volume-14,-number-1-(janfeb-2023)\/the-role-of-the-research-advanced-practice-provider-in-car-t-cell-clinical-trials.aspx"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,1]]},"published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.6004\/jadpro.2023.14.1.5","relation":{},"ISSN":["2150-0878"],"issn-type":[{"value":"2150-0878","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}